81 results on '"Seeger, Werner"'
Search Results
2. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis
3. Native hepatic T1-time as a non-invasive predictor of diastolic dysfunction and a monitoring tool for disease progression and treatment response in patients with pulmonary hypertension
4. Right ventricular pressure-strain relationship-derived myocardial work reflects contractility: Validation with invasive pressure-volume analysis
5. Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension
6. The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension
7. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
8. Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension
9. Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis
10. Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
11. Impact of litter size on survival, growth and lung alveolarization of newborn mouse pups
12. Risk assessment in severe pulmonary hypertension due to interstitial lung disease
13. Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality
14. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
15. Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension
16. In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed
17. Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension
18. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice
19. Cancer cell motility is affected through 3D cell culturing and SCF/c-Kit pathway but not by X-irradiation
20. Influence of amine-modified poly(vinyl alcohol)s on vibrating-membrane nebulizer performance and lung toxicity
21. Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles
22. Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension
23. Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: Role of surfactant protein B and C
24. Controlling the droplet size of formulations nebulized by vibrating-membrane technology
25. Nebulization of Active Pharmaceutical Ingredients with the eFlow®rapid: Impact of Formulation Variables on Aerodynamic Characteristics
26. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions
27. Pulmonary Hypertension in Chronic Lung Diseases
28. Pulmonary Hypertension Due to Left Heart Diseases
29. Updated Treatment Algorithm of Pulmonary Arterial Hypertension
30. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors
31. Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations
32. Sleep apnea in precapillary pulmonary hypertension
33. BDNF/TrkB Signaling Augments Smooth Muscle Cell Proliferation in Pulmonary Hypertension
34. Paxillin Regulates Pulmonary Arterial Smooth Muscle Cell Function in Pulmonary Hypertension
35. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers
36. Quality of life in clinically stable adult cystic fibrosis out-patients: Associations with daytime sleepiness and sleep quality
37. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery
38. Development of a biodegradable nanoparticle platform for sildenafil: Formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters
39. Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension
40. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro
41. Comparison of the Effects of Carbon Ion and Photon Irradiation on the Angiogenic Response in Human Lung Adenocarcinoma Cells
42. Worldwide Physician Education and Training in Pulmonary Hypertension: Pulmonary Vascular Disease: The Global Perspective
43. HIF-1α signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells
44. Asthma bronchiale
45. Animal models of pulmonary hypertension: role in translational research
46. Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension
47. Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells
48. A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy: A Pooled Analysis of Five Studies With Recombinant Surfactant Protein-C Surfactant (Venticute)
49. Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: Impact on adhesion and apoptosis
50. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.